Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population

Ariel Pablos-Méndez, Richard Mayeux, Colleen Ngai, Steven Shea, Lars Berglund

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Apolipoprotein E polymorphisms are important determinants of blood lipid levels and have been associated with longevity and atherosclerosis. However, information is limited on the effects of apo E variation on the lipids of nonwhite and elderly individuals. We tested the hypothesis that ape E polymorphisms are associated with plasma lipid levels in an elderly, multiethnic population. Cross-sectional data from 1068 noninstitutionalized individuals from northern Manhattan over the age of 64 who were not on a lipid-lowering diet or drug were analyzed. The ethnic distribution was 34% African-Americans, 47% Hispanics, and 19% non-Hispanic Caucasians. In the entire group, the most prevalent ape E allele was ε3 (76%), followed by ε4 (16%) and ε2 (8%); ε4 was more prevalent in African-Americans (21%) than in non-Hispanic Caucasians (12%) or Hispanics (14%). The apo ε2 allele was the most important correlate of plasma lipids, but this association varied across ethnoracial groups. After being adjusted for age, sex, obesity, diabetes mellitus, and alcohol intake, LDL cholesterol levels declined with each ape ε2 allele by 8.8 mg/dL in Hispanics and by 25.6 and 18.1 mg/dL in non- Hispanic Caucasians and African-Americans, respectively (P<.001). No significant independent effect was noted for any ape E genotype on HDL cholesterol. Overall, there was a reduction in the total/HDL cholesterol ratio, per apo ε2 allele, of 0.82 in non-Hispanic Caucasians and 0.43 and 0.48 in African-American and Hispanic individuals, respectively (P<.05). In a multivariate model, apo ε4 did not significantly affect plasma lipid levels. Plasma triglyceride levels were inversely correlated with the number of apo ε4 alleles (175, 159, and 143 mg/dL with 0, 1, and 2 alleles, respectively; P =.002), and this effect increased with age. Thus, in an elderly, multiethnic population, apolipoprotein E polymorphisms were important determinants of blood lipids, with differing effects depending on ethnicity. The presence of apo ε2 was associated with lower LDL cholesterol levels and total/HDL cholesterol ratio, although apo ε genotype did not influence HDL cholesterol levels. Prospective studies are needed to test whether apo ε2 protects against incident cardiovascular disease in the elderly.

Original languageEnglish (US)
Pages (from-to)3534-3541
Number of pages8
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume17
Issue number12
StatePublished - 1997
Externally publishedYes

Fingerprint

Apolipoproteins E
Hispanic Americans
Lipids
Alleles
Hominidae
African Americans
HDL Cholesterol
Population
LDL Cholesterol
Genotype
Atherosclerosis
Diabetes Mellitus
Triglycerides
Cardiovascular Diseases
Obesity
Alcohols
Prospective Studies
Diet
Pharmaceutical Preparations

Keywords

  • Apo E
  • Elderly
  • Epidemiology
  • Genetics
  • Serum lipids

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population. / Pablos-Méndez, Ariel; Mayeux, Richard; Ngai, Colleen; Shea, Steven; Berglund, Lars.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 17, No. 12, 1997, p. 3534-3541.

Research output: Contribution to journalArticle

Pablos-Méndez, Ariel ; Mayeux, Richard ; Ngai, Colleen ; Shea, Steven ; Berglund, Lars. / Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 1997 ; Vol. 17, No. 12. pp. 3534-3541.
@article{8a213ff5f5d647e099a47434aaa1f294,
title = "Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population",
abstract = "Apolipoprotein E polymorphisms are important determinants of blood lipid levels and have been associated with longevity and atherosclerosis. However, information is limited on the effects of apo E variation on the lipids of nonwhite and elderly individuals. We tested the hypothesis that ape E polymorphisms are associated with plasma lipid levels in an elderly, multiethnic population. Cross-sectional data from 1068 noninstitutionalized individuals from northern Manhattan over the age of 64 who were not on a lipid-lowering diet or drug were analyzed. The ethnic distribution was 34{\%} African-Americans, 47{\%} Hispanics, and 19{\%} non-Hispanic Caucasians. In the entire group, the most prevalent ape E allele was ε3 (76{\%}), followed by ε4 (16{\%}) and ε2 (8{\%}); ε4 was more prevalent in African-Americans (21{\%}) than in non-Hispanic Caucasians (12{\%}) or Hispanics (14{\%}). The apo ε2 allele was the most important correlate of plasma lipids, but this association varied across ethnoracial groups. After being adjusted for age, sex, obesity, diabetes mellitus, and alcohol intake, LDL cholesterol levels declined with each ape ε2 allele by 8.8 mg/dL in Hispanics and by 25.6 and 18.1 mg/dL in non- Hispanic Caucasians and African-Americans, respectively (P<.001). No significant independent effect was noted for any ape E genotype on HDL cholesterol. Overall, there was a reduction in the total/HDL cholesterol ratio, per apo ε2 allele, of 0.82 in non-Hispanic Caucasians and 0.43 and 0.48 in African-American and Hispanic individuals, respectively (P<.05). In a multivariate model, apo ε4 did not significantly affect plasma lipid levels. Plasma triglyceride levels were inversely correlated with the number of apo ε4 alleles (175, 159, and 143 mg/dL with 0, 1, and 2 alleles, respectively; P =.002), and this effect increased with age. Thus, in an elderly, multiethnic population, apolipoprotein E polymorphisms were important determinants of blood lipids, with differing effects depending on ethnicity. The presence of apo ε2 was associated with lower LDL cholesterol levels and total/HDL cholesterol ratio, although apo ε genotype did not influence HDL cholesterol levels. Prospective studies are needed to test whether apo ε2 protects against incident cardiovascular disease in the elderly.",
keywords = "Apo E, Elderly, Epidemiology, Genetics, Serum lipids",
author = "Ariel Pablos-M{\'e}ndez and Richard Mayeux and Colleen Ngai and Steven Shea and Lars Berglund",
year = "1997",
language = "English (US)",
volume = "17",
pages = "3534--3541",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population

AU - Pablos-Méndez, Ariel

AU - Mayeux, Richard

AU - Ngai, Colleen

AU - Shea, Steven

AU - Berglund, Lars

PY - 1997

Y1 - 1997

N2 - Apolipoprotein E polymorphisms are important determinants of blood lipid levels and have been associated with longevity and atherosclerosis. However, information is limited on the effects of apo E variation on the lipids of nonwhite and elderly individuals. We tested the hypothesis that ape E polymorphisms are associated with plasma lipid levels in an elderly, multiethnic population. Cross-sectional data from 1068 noninstitutionalized individuals from northern Manhattan over the age of 64 who were not on a lipid-lowering diet or drug were analyzed. The ethnic distribution was 34% African-Americans, 47% Hispanics, and 19% non-Hispanic Caucasians. In the entire group, the most prevalent ape E allele was ε3 (76%), followed by ε4 (16%) and ε2 (8%); ε4 was more prevalent in African-Americans (21%) than in non-Hispanic Caucasians (12%) or Hispanics (14%). The apo ε2 allele was the most important correlate of plasma lipids, but this association varied across ethnoracial groups. After being adjusted for age, sex, obesity, diabetes mellitus, and alcohol intake, LDL cholesterol levels declined with each ape ε2 allele by 8.8 mg/dL in Hispanics and by 25.6 and 18.1 mg/dL in non- Hispanic Caucasians and African-Americans, respectively (P<.001). No significant independent effect was noted for any ape E genotype on HDL cholesterol. Overall, there was a reduction in the total/HDL cholesterol ratio, per apo ε2 allele, of 0.82 in non-Hispanic Caucasians and 0.43 and 0.48 in African-American and Hispanic individuals, respectively (P<.05). In a multivariate model, apo ε4 did not significantly affect plasma lipid levels. Plasma triglyceride levels were inversely correlated with the number of apo ε4 alleles (175, 159, and 143 mg/dL with 0, 1, and 2 alleles, respectively; P =.002), and this effect increased with age. Thus, in an elderly, multiethnic population, apolipoprotein E polymorphisms were important determinants of blood lipids, with differing effects depending on ethnicity. The presence of apo ε2 was associated with lower LDL cholesterol levels and total/HDL cholesterol ratio, although apo ε genotype did not influence HDL cholesterol levels. Prospective studies are needed to test whether apo ε2 protects against incident cardiovascular disease in the elderly.

AB - Apolipoprotein E polymorphisms are important determinants of blood lipid levels and have been associated with longevity and atherosclerosis. However, information is limited on the effects of apo E variation on the lipids of nonwhite and elderly individuals. We tested the hypothesis that ape E polymorphisms are associated with plasma lipid levels in an elderly, multiethnic population. Cross-sectional data from 1068 noninstitutionalized individuals from northern Manhattan over the age of 64 who were not on a lipid-lowering diet or drug were analyzed. The ethnic distribution was 34% African-Americans, 47% Hispanics, and 19% non-Hispanic Caucasians. In the entire group, the most prevalent ape E allele was ε3 (76%), followed by ε4 (16%) and ε2 (8%); ε4 was more prevalent in African-Americans (21%) than in non-Hispanic Caucasians (12%) or Hispanics (14%). The apo ε2 allele was the most important correlate of plasma lipids, but this association varied across ethnoracial groups. After being adjusted for age, sex, obesity, diabetes mellitus, and alcohol intake, LDL cholesterol levels declined with each ape ε2 allele by 8.8 mg/dL in Hispanics and by 25.6 and 18.1 mg/dL in non- Hispanic Caucasians and African-Americans, respectively (P<.001). No significant independent effect was noted for any ape E genotype on HDL cholesterol. Overall, there was a reduction in the total/HDL cholesterol ratio, per apo ε2 allele, of 0.82 in non-Hispanic Caucasians and 0.43 and 0.48 in African-American and Hispanic individuals, respectively (P<.05). In a multivariate model, apo ε4 did not significantly affect plasma lipid levels. Plasma triglyceride levels were inversely correlated with the number of apo ε4 alleles (175, 159, and 143 mg/dL with 0, 1, and 2 alleles, respectively; P =.002), and this effect increased with age. Thus, in an elderly, multiethnic population, apolipoprotein E polymorphisms were important determinants of blood lipids, with differing effects depending on ethnicity. The presence of apo ε2 was associated with lower LDL cholesterol levels and total/HDL cholesterol ratio, although apo ε genotype did not influence HDL cholesterol levels. Prospective studies are needed to test whether apo ε2 protects against incident cardiovascular disease in the elderly.

KW - Apo E

KW - Elderly

KW - Epidemiology

KW - Genetics

KW - Serum lipids

UR - http://www.scopus.com/inward/record.url?scp=0031471572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031471572&partnerID=8YFLogxK

M3 - Article

C2 - 9437203

AN - SCOPUS:0031471572

VL - 17

SP - 3534

EP - 3541

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 12

ER -